Duncker Streett & CO Inc Anavex Life Sciences Corp. Transaction History

Duncker Streett & CO Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$9.74 - $17.69 $487 - $884	-50 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$2.31 - $3.14 $115 - $157	50 New	50 $0
Q3 2019 Oct 31, 2019	SELL	$2.22 - $3.9 $111 - $195	-50 Closed	0 $0
Q3 2017 Oct 25, 2017	BUY	$3.42 - $4.87 $171 - $243	50	50 $0

161

27.4M

515K

838K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $818M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Duncker Streett & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Duncker Streett & CO Inc with notifications on news.